A critical analysis and discussion of the appropriateness of the schizophrenia consensus remission criteria in clinical pharmaceutical trials.

  • R Schennach-Wolff
  • H-J Möller
  • M Jäger
  • F Seemüller
  • M Obermeier
  • T Messer
  • G Laux
  • H Pfeiffer
  • Dieter Naber
  • L G Schmidt
  • W Gaebel
  • J Klosterkötter
  • I Heuser
  • W Maier
  • M R Lemke
  • E Rüther
  • S Klingberg
  • M Gastpar
  • M Riedel

Abstract

The aim of this paper is to apply the proposed consensus remission criteria to an acutely ill inpatient sample at admission and evaluate their adaptability in this patient population and pharmaceutical trials.

Bibliografische Daten

OriginalspracheDeutsch
Aufsatznummer7
ISSN0176-3679
StatusVeröffentlicht - 2010
pubmed 20927697